GE HealthCare Technologies Inc. vs Abbott Laboratories
A head-to-head of GE HealthCare Technologies Inc. (GEHC) and Abbott Laboratories (ABT) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | GEHC | ABT |
|---|---|---|
| Market Cap | $28.69B | $175.37B |
| P/E (TTM) | 15.09 | 28.20 |
| Forward P/E | 11.18 | 16.60 |
| P/S | 1.32 | 3.56 |
| P/B | 2.66 | 3.82 |
| EV/EBITDA | 10.08 | 15.88 |
| Dividend Yield | 0.22% | 2.08% |
| Profit Margin | 9.10% | 13.91% |
| Gross Margin | 39.99% | 56.42% |
| Operating Margin | 13.39% | 18.17% |
| Revenue Growth (YoY) | +7.41% | +7.78% |
| FCF Yield | 5.49% | 4.59% |
| Debt / Equity | 92.99 | 64.60 |
| Current Ratio | 1.22 | 1.39 |
Which is better: GE HealthCare Technologies Inc. or Abbott Laboratories?
- ✓Larger by market cap: Abbott Laboratories
- ✓Cheaper valuation (lower P/E): GE HealthCare Technologies Inc.
- ✓Higher dividend yield: Abbott Laboratories
- ✓More profitable (net margin): Abbott Laboratories
- ✓Faster revenue growth: Abbott Laboratories
- ✓Higher free-cash-flow yield: GE HealthCare Technologies Inc.
Across 13 available metrics, Abbott Laboratories leads 7–6.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.